{"id":561090,"date":"2025-11-27T00:15:24","date_gmt":"2025-11-27T00:15:24","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/561090\/"},"modified":"2025-11-27T00:15:24","modified_gmt":"2025-11-27T00:15:24","slug":"valneva-regroupe-ses-activites-francaises-a-lyon","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/561090\/","title":{"rendered":"Valneva regroupe ses activit\u00e9s fran\u00e7aises \u00e0 Lyon"},"content":{"rendered":"<p>Dans le cadre de cette \u00ab consolidation des activit\u00e9s \u00bb, Valneva a pr\u00e9vu de fermer son site de Nantes qui compte actuellement des activit\u00e9s op\u00e9rationnelles ainsi que certaines activit\u00e9s de recherche et d\u00e9veloppement pr\u00e9clinique, selon un communiqu\u00e9.<\/p>\n<p>L&rsquo;ensemble des activit\u00e9s de recherche et d\u00e9veloppement (R&amp;D) sera centralis\u00e9 \u00e0 Vienne, en Autriche, selon <a href=\"https:\/\/www.leprogres.fr\/sante\/2025\/08\/25\/chikungunya-le-vaccin-ixchiq-suspendu-aux-etats-unis-apres-de-nouveaux-effets-indesirables\" target=\"_blank\" rel=\"noopener\">Valneva<\/a>, qui envisage de rapatrier son si\u00e8ge social \u00e0 Lyon, ville o\u00f9 il \u00e9tait initialement implant\u00e9 et qui est \u00ab reconnue \u00e0 l\u2019international comme un p\u00f4le majeur dans le domaine des vaccins \u00bb.<\/p>\n<p>Trente personnes concern\u00e9es<\/p>\n<p>Cette initiative permettra \u00ab de rationaliser les op\u00e9rations et d&rsquo;am\u00e9liorer l&rsquo;efficacit\u00e9 en France \u00bb, indique le communiqu\u00e9.<\/p>\n<p>\u00ab Trente personnes sont concern\u00e9es par cette r\u00e9organisation \u00bb, a pr\u00e9cis\u00e9 \u00e0 l&rsquo;AFP la soci\u00e9t\u00e9, qui dit s&rsquo;engager \u00e0 \u00ab accompagner ses employ\u00e9s tout au long de cette transition \u00bb.<\/p>\n<p>Issue de la fusion en 2013 du sp\u00e9cialiste autrichien des vaccins Intercell et du fran\u00e7ais Vivalis, Valneva commercialise actuellement trois vaccins du voyage: contre le chikungunya (Ixchiq), contre l&rsquo;enc\u00e9phalite japonaise (Ixiaro) et contre le chol\u00e9ra (Dukoral).<\/p>\n<p>La soci\u00e9t\u00e9 d\u00e9veloppe aussi un candidat vaccin (en partenariat avec Pfizer), contre la <a href=\"https:\/\/www.leprogres.fr\/societe\/2025\/06\/07\/maladie-de-lyme-encephalites-attention-c-est-le-pic-d-activite-des-tiques\" target=\"_blank\" rel=\"noopener\">maladie de Lyme<\/a>, transmise par des tiques, un autre contre la shigellose, maladie infectieuse de l\u2019intestin, et enfin contre le virus Zika transmis par des moustiques.<\/p>\n","protected":false},"excerpt":{"rendered":"Dans le cadre de cette \u00ab consolidation des activit\u00e9s \u00bb, Valneva a pr\u00e9vu de fermer son site de&hellip;\n","protected":false},"author":2,"featured_media":561091,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1889],"tags":[1111,11,2430,33,2757,1777,674,107,1011,27,693,2428,12,25,2429,71],"class_list":{"0":"post-561090","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-lyon","8":"tag-actu","9":"tag-actualites","10":"tag-auvergne-rhone-alpes","11":"tag-economie","12":"tag-edition-lyon-villeurbanne","13":"tag-eu","14":"tag-europe","15":"tag-fil-info","16":"tag-fr","17":"tag-france","18":"tag-industrie","19":"tag-lyon","20":"tag-news","21":"tag-republique-francaise","22":"tag-rhone","23":"tag-sante"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115618783170334710","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/561090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=561090"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/561090\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/561091"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=561090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=561090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=561090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}